Pulse Biosciences (PLSE) Cost of Revenue (2021 - 2025)

Pulse Biosciences has reported Cost of Revenue over the past 3 years, most recently at $279000.0 for Q3 2025.

  • Quarterly results put Cost of Revenue at $279000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $279000.0 (changed N/A YoY), and the annual figure for FY2022 was $11.9 million, up 506.91%.
  • Cost of Revenue for Q3 2025 was $279000.0 at Pulse Biosciences, down from $1.3 million in the prior quarter.
  • Over the last five years, Cost of Revenue for PLSE hit a ceiling of $8.4 million in Q3 2022 and a floor of $279000.0 in Q3 2025.
  • Median Cost of Revenue over the past 3 years was $1.2 million (2021), compared with a mean of $2.0 million.
  • Peak annual rise in Cost of Revenue hit 1055.43% in 2022, while the deepest fall reached 4.03% in 2022.
  • Pulse Biosciences' Cost of Revenue stood at $1.2 million in 2021, then rose by 4.03% to $1.3 million in 2022, then tumbled by 78.39% to $279000.0 in 2025.
  • The last three reported values for Cost of Revenue were $279000.0 (Q3 2025), $1.3 million (Q4 2022), and $8.4 million (Q3 2022) per Business Quant data.